35 related articles for article (PubMed ID: 22916521)
1. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
[No Abstract] [Full Text] [Related]
3. Practical management of chronic hepatitis B infection.
Tsai NC
Semin Liver Dis; 2004; 24 Suppl 1():71-6. PubMed ID: 15192804
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of HBV infection during pregnancy.
Piratvisuth T
Liver Int; 2013 Feb; 33 Suppl 1():188-94. PubMed ID: 23286864
[TBL] [Abstract][Full Text] [Related]
5. DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.
Mak LY; Seto WK; Lai CL; Yuen MF
Expert Opin Drug Saf; 2016; 15(3):383-92. PubMed ID: 26752687
[TBL] [Abstract][Full Text] [Related]
6. [Updates of EASL clinical practice guidelines: management of chronic hepatitis B virus infection].
Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):427-9. PubMed ID: 23230593
[No Abstract] [Full Text] [Related]
7. [Indications and opportunities for antiviral therapy to treat chronic HBV infection in women of childbearing age and during pregnancy].
Guorong H; Ding Y
Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):806-9. PubMed ID: 27249851
[No Abstract] [Full Text] [Related]
8. [Pregnancy-related factors and antiviral treatment for chronic hepatitis B].
Xinye C; Shibin Z; Junfeng L
Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):803-5. PubMed ID: 27249850
[No Abstract] [Full Text] [Related]
9. Principles in the management of chronic hepatitis B viral infection.
Minuk GY
Can J Gastroenterol; 1999; 13(1):75-7. PubMed ID: 10099818
[TBL] [Abstract][Full Text] [Related]
10. NIH consensus development conference: management of Hepatitis B. Introduction.
Doo EC; Hoofnagle JH; Rodgers GP
Hepatology; 2009 May; 49(5 Suppl):S1-3. PubMed ID: 19399814
[No Abstract] [Full Text] [Related]
11. The cost of managing chronic hepatitis B infection: a global perspective.
Kowdley KV
J Clin Gastroenterol; 2004; 38(10 Suppl 3):S132-3. PubMed ID: 15602159
[No Abstract] [Full Text] [Related]
12. Minority Report: ENUMERATing Treatment of Chronic HBV Infection Among Asian-American Communities.
Pham C; Kuo A
Dig Dis Sci; 2019 Feb; 64(2):289-291. PubMed ID: 30390233
[No Abstract] [Full Text] [Related]
13. Approach to chronic hepatitis B virus infection.
Tyagi P; Arora A
JNMA J Nepal Med Assoc; 2011; 51(182):94-101. PubMed ID: 22916521
[TBL] [Abstract][Full Text] [Related]
14. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
15. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.
Pan CQ; Hu KQ; Yu AS; Chen W; Bunchorntavakul C; Reddy KR
J Viral Hepat; 2012 Mar; 19(3):213-9. PubMed ID: 22329376
[TBL] [Abstract][Full Text] [Related]
16. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
